About tezepelumab
Thymic stromal lymphopoietin-blocking monoclonal antibody
Used for
- Add-on maintenance treatment for severe asthma in adults and children aged 12 years or older.
Usual adult dose
210 mg under the skin every four weeks.
Usual dose in children
For ages 12 years and older: 210 mg under the skin every four weeks.
Common side effects
- Sore throat
- Joint pain
- Back pain
- Injection-site reactions
Important warnings
- Not for treating sudden asthma attacks or acute breathing problems.
- Serious allergic reactions, including anaphylaxis, can occur.
- Do not stop or reduce inhaled or oral corticosteroids suddenly.
- Treat existing parasitic worm infections before starting; seek assessment if infection develops.
Pregnancy
Human pregnancy data are limited; use only when potential benefit justifies potential fetal risk.
Breastfeeding
It is unknown whether tezepelumab passes into human milk; discuss potential benefits and risks.
Interactions
- No specific drug interactions are established; formal interaction studies are limited.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.